229 related articles for article (PubMed ID: 16393674)
41. Ladarixin, a dual CXCR1/2 inhibitor, attenuates experimental melanomas harboring different molecular defects by affecting malignant cells and tumor microenvironment.
Kemp DM; Pidich A; Larijani M; Jonas R; Lash E; Sato T; Terai M; De Pizzol M; Allegretti M; Igoucheva O; Alexeev V
Oncotarget; 2017 Feb; 8(9):14428-14442. PubMed ID: 28129639
[TBL] [Abstract][Full Text] [Related]
42. Cross-desensitization among CXCR1, CXCR2, and CCR5: role of protein kinase C-epsilon.
Nasser MW; Marjoram RJ; Brown SL; Richardson RM
J Immunol; 2005 Jun; 174(11):6927-33. PubMed ID: 15905535
[TBL] [Abstract][Full Text] [Related]
43. COX-2 expression in malignant melanoma: a novel prognostic marker?
Becker MR; Siegelin MD; Rompel R; Enk AH; Gaiser T
Melanoma Res; 2009 Feb; 19(1):8-16. PubMed ID: 19430402
[TBL] [Abstract][Full Text] [Related]
44. An updated review on the role of the CXCL8-CXCR1/2 axis in the progression and metastasis of breast cancer.
Mishra A; Suman KH; Nair N; Majeed J; Tripathi V
Mol Biol Rep; 2021 Sep; 48(9):6551-6561. PubMed ID: 34426905
[TBL] [Abstract][Full Text] [Related]
45. Interleukin 8 mediates bcl-xL-induced enhancement of human melanoma cell dissemination and angiogenesis in a zebrafish xenograft model.
Gabellini C; Gómez-Abenza E; Ibáñez-Molero S; Tupone MG; Pérez-Oliva AB; de Oliveira S; Del Bufalo D; Mulero V
Int J Cancer; 2018 Feb; 142(3):584-596. PubMed ID: 28949016
[TBL] [Abstract][Full Text] [Related]
46. Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases.
Ha H; Debnath B; Neamati N
Theranostics; 2017; 7(6):1543-1588. PubMed ID: 28529637
[TBL] [Abstract][Full Text] [Related]
47. CXCR2 Expression on neutrophils is upregulated during the relapsing phase of ocular Behcet disease.
Qiao H; Sonoda KH; Ariyama A; Kuratomi Y; Kawano Y; Ishibashi T
Curr Eye Res; 2005 Mar; 30(3):195-203. PubMed ID: 15804745
[TBL] [Abstract][Full Text] [Related]
48. Alpha-chemokines regulate proliferation, neurogenesis, and dopaminergic differentiation of ventral midbrain precursors and neurospheres.
Edman LC; Mira H; Erices A; Malmersjö S; Andersson E; Uhlén P; Arenas E
Stem Cells; 2008 Jul; 26(7):1891-900. PubMed ID: 18436867
[TBL] [Abstract][Full Text] [Related]
49. A comprehensive analysis of the angiogenesis-related genes in glioblastoma multiforme vs. brain lower grade glioma.
Biterge-Sut B
Arq Neuropsiquiatr; 2020 Jan; 78(1):34-38. PubMed ID: 32074192
[TBL] [Abstract][Full Text] [Related]
50. 3,4-Diamino-2,5-thiadiazole-1-oxides as potent CXCR2/CXCR1 antagonists.
Biju P; Taveras A; Yu Y; Zheng J; Chao J; Rindgen D; Jakway J; Hipkin RW; Fossetta J; Fan X; Fine J; Qiu H; Merritt JR; Baldwin JJ
Bioorg Med Chem Lett; 2008 Jan; 18(1):228-31. PubMed ID: 18006311
[TBL] [Abstract][Full Text] [Related]
51. Association of interleukin-8 (IL-8 or CXCL8) -251T/A and CXCR2 +1208C/T gene polymorphisms with breast cancer.
Kamali-Sarvestani E; Aliparasti MR; Atefi S
Neoplasma; 2007; 54(6):484-9. PubMed ID: 17949231
[TBL] [Abstract][Full Text] [Related]
52. C(4)-alkyl substituted furanyl cyclobutenediones as potent, orally bioavailable CXCR2 and CXCR1 receptor antagonists.
Chao J; Taveras AG; Chao J; Aki C; Dwyer M; Yu Y; Purakkattle B; Rindgen D; Jakway J; Hipkin W; Fosetta J; Fan X; Lundell D; Fine J; Minnicozzi M; Phillips J; Merritt JR
Bioorg Med Chem Lett; 2007 Jul; 17(13):3778-83. PubMed ID: 17459706
[TBL] [Abstract][Full Text] [Related]
53. Effects of K11R and G31P Mutations on the Structure and Biological Activities of CXCL8: Solution Structure of Human CXCL8
Cheng HT; Yu HY; Gordon JR; Li F; Cheng JW
Molecules; 2017 Jul; 22(7):. PubMed ID: 28754019
[TBL] [Abstract][Full Text] [Related]
54. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in human malignant melanoma and their relation to angiogenesis.
Tu YT; Tao J; Liu YQ; Li Y; Huang CZ; Zhang XB; Lin Y
Clin Exp Dermatol; 2006 May; 31(3):413-8. PubMed ID: 16681591
[TBL] [Abstract][Full Text] [Related]
55. Gene expression signatures for tumor progression, tumor subtype, and tumor thickness in laser-microdissected melanoma tissues.
Jaeger J; Koczan D; Thiesen HJ; Ibrahim SM; Gross G; Spang R; Kunz M
Clin Cancer Res; 2007 Feb; 13(3):806-15. PubMed ID: 17289871
[TBL] [Abstract][Full Text] [Related]
56. CXCL8 modulates human intestinal epithelial cells through a CXCR1 dependent pathway.
Sturm A; Baumgart DC; d'Heureuse JH; Hotz A; Wiedenmann B; Dignass AU
Cytokine; 2005 Jan; 29(1):42-8. PubMed ID: 15579377
[TBL] [Abstract][Full Text] [Related]
57. Small-molecule antagonists for CXCR2 and CXCR1 inhibit human melanoma growth by decreasing tumor cell proliferation, survival, and angiogenesis.
Singh S; Sadanandam A; Nannuru KC; Varney ML; Mayer-Ezell R; Bond R; Singh RK
Clin Cancer Res; 2009 Apr; 15(7):2380-6. PubMed ID: 19293256
[TBL] [Abstract][Full Text] [Related]
58. Analysis of CXCL8 and its receptors CXCR1/CXCR2 at the mRNA level in neoplastic tissue, as well as in serum and peritoneal fluid in patients with ovarian cance.
Smycz-Kubańska M; Stępień S; Gola JM; Kruszniewska-Rajs C; Wendlocha D; Królewska-Daszczyńska P; Strzelec A; Strzelczyk J; Szanecki W; Witek A; Mielczarek-Palacz A
Mol Med Rep; 2022 Oct; 26(4):. PubMed ID: 35920183
[TBL] [Abstract][Full Text] [Related]
59. Host CXCR2-dependent regulation of melanoma growth, angiogenesis, and experimental lung metastasis.
Singh S; Varney M; Singh RK
Cancer Res; 2009 Jan; 69(2):411-5. PubMed ID: 19147552
[TBL] [Abstract][Full Text] [Related]
60. Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis.
Wente MN; Keane MP; Burdick MD; Friess H; Büchler MW; Ceyhan GO; Reber HA; Strieter RM; Hines OJ
Cancer Lett; 2006 Sep; 241(2):221-7. PubMed ID: 16458421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
